CellsBin
PrivateLast Round
Series A
Sep 22, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellsBin is a biotechnology company that develops a Rare-Cell Intelligence™ platform integrating microfluidics, multimodal imaging, single-cell analysis, and artificial intelligence to detect and monitor rare cells for precision medicine applications.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellsBin Comparables
Compare CellsBin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TellBio Inc. | 86% | |
| Vortex Biosciences | 86% | |
| RareCyte | 81% |
CellsBin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2026 | ||||
| Accelerator | Dec 1, 2025 | ||||
| Seed | Sep 24, 2024 |
Key People
Founding team and executive leadership
CellsBin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed |
| 108 BioCapital | Series A |
| Endless Frontier Labs | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
Led by 108 BioCapital
- Jul 26, 2026
Monthly visitors grew 219% MoM, reaching 2.3K.
Recent news
Latest coverage and updates
- increases_headcount_bySep 22, 2026
CellsBin Inc. increased headcount by 6 on Sep 22nd '26.
CellsBin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellsBin's valuation, stock price, and market status.
Is CellsBin a public or private company?
CellsBin is a private company.
What is the current stock price of CellsBin?
CellsBin is a private company with no public stock price. Caplight tracks CellsBin's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CellsBin worth (valuation)?
Valuation information for CellsBin is not publicly available.
Can I buy CellsBin stock?
CellsBin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CellsBin's last funding round?
CellsBin's most recent funding round was Series A on September 22, 2026.
Who are the main investors in CellsBin?
Key investors in CellsBin include 108 BioCapital.
Will CellsBin IPO soon?
No public IPO plans have been announced for CellsBin.
How can I track CellsBin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellsBin's secondary market activity and sign up for updates.